Safety and efficacy of polatuzumab vedotin + obinutuzumab for relapsed/refractory non‐Hodgkin lymphomas: A phase IB/II study. Issue 1 (30th November 2021)

Record Type:
Journal Article
Title:
Safety and efficacy of polatuzumab vedotin + obinutuzumab for relapsed/refractory non‐Hodgkin lymphomas: A phase IB/II study. Issue 1 (30th November 2021)
Main Title:
Safety and efficacy of polatuzumab vedotin + obinutuzumab for relapsed/refractory non‐Hodgkin lymphomas: A phase IB/II study
Authors:
Phillips, Tycel
Brunvand, Mark
Chen, Andy I.
Essell, James
Chiappella, Annalisa
Diefenbach, Catherine
Cheng, Ji
Ramies, David
Hirata, Jamie
Morschhauser, Franck
Flinn, Ian W.
Abstract:
Is Part Of:
American journal of hematology. Volume 97:Issue 1(2022)
Journal:
American journal of hematology
Issue:
Volume 97:Issue 1(2022)
Issue Display:
Volume 97, Issue 1 (2022)
Year:
2022
Volume:
97
Issue:
1
Issue Sort Value:
2022-0097-0001-0000
Page Start:
E24
Page End:
E27
Publication Date:
2021-11-30
Subjects:
Hematology -- Periodicals
616.15
Journal URLs:
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1096-8652 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:
10.1002/ajh.26400 ↗
Languages:
English
ISSNs:
0361-8609
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 0824.800000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
25855.xml